Next-Generation Sequencing Market

Global Next-Generation Sequencing (NGS) Market, By Technology (Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Targeted Re-sequencing and Others), By Application (Drug Discovery, Personalized Medicine & Genetic Screening, Disease Diagnosis, Agriculture & Animal Research and Others), By End User (Hospitals, Research Centers Pharma & Biotech Firms and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029

PMI140719 | Clinical Diagnostic

Sep 2019 | 168 | PDF

Global next-generation sequencing (NGS) market report published by Prophecy Market Insights offers holistic view of various influencing factors and aims to answer all the target market related questions.

The research scope provides comprehensive market size, and other in-depth market information details such as, market growth supporting factors, restraining factors, trends, opportunities, market risk factors, market competition, product and services advancements and launches, product/services related regulations overview, and recent developments for the mentioned forecast period. In addition, the report provides key examination of market players operating in the specific market and analysis and outcomes related with the target market for more than 20 countries.

Simley face

In the current research scope 2018 is considered as base year and 2019 is estimated year for market value/volume calculations. The report offers market estimates for the forecast period – 2019 to 2029. The report provides factual inputs and analysis based on primary and secondary research, which includes insights gained through in-depth interviews with primary research participants. Also, the data is gathered from authentic secondary sources and is verified by key opinion leaders in the target market. The in-house research is applied on gathered information to provide more accurate data points and reduce the margin of error. The in-house research and analysis efforts include various tools and 360o data analysis methodology.

The global next-generation sequencing (NGS) market report segments the market on the basis of technology, application, end user, and region.

The report expected to answer various target market related questions and offers insights on:

  • Definition, description, overview of market growth influencing factors, and forecast for the target market
  • Scope for related market in the forecast period
  • Analysis and outcome for the global next-generation sequencing (NGS) market by segment and region followed by countries
  • Market segmentation, dominating segment and region followed by country along with market value, share, Y-o-Y growth, CAGR, forecast, and contribution in the market
  • Key market player profiles, their recent developments, strategies, financial details, key competencies, presence by region, and product portfolio
  • Valuable insights, data, and forecast that can be referenced to plan business strategies, to tap market opportunities, understand business related risks, derive business goals, to recognize trends, and understand target customers/end users
  • Insights on recent technologies, pipeline products, regulations related with target market, market investment, and offers insights on political and economic factors that may influence market growth
  • PEST Analysis, PORTER’s five forces analysis, opportunity map analysis, drivers and restraints impact analysis, and market attractiveness index

Key players in the global next-generation sequencing (NGS) market include:

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • QIAGEN LLC
  • PierianDx, Inc.
  • F Hoffman-La Roche Ltd.
  • Genomatix GmbH
  • Oxford Nanopore Technologies, Inc.
  • Eurofins GATC Biotech GmbH
  • DNASTAR, Inc.
  • Perkin Elmer, Inc.
  • Bio-Rad Laboratories, Inc.

Prophecy Market Insights offers required customization on this report according to specific business requirements.

Overview:

Next generation sequencing(NGS) is a high throughput deep sequencing technology that enables sequencing of the base pairs present in the DNA or RNA samples. It is a revolution in the biological sciences which has enabled researchers to perform a variety of studies which were never possible before. This is done by using ultra-high throughput, scalability, and speed of next generation sequencing. NGS helps to utilize RNA sequencing (RNA-Seq) to discover novel RNA variants and splice sites, or quantify mRNAs for gene expression analysis and study microbial diversity in humans or in the environment. Further, it allows researchers to rapidly sequence whole genomes and zoom in to deeply sequence target regions which help for the personalized medicine and other different types of treatment.

Market Dynamics:

The global next-generation sequencing (NGS) market is mainly driven by the factor that it allows early detection of cancer and other infectious diseases which is of a major concern to the researchers for the development of anti-cancer drugs. For instance, according to International Agency for Research on Cancer, 2018, there were total 18,078,957 new cancer cases in both sexes and all ages were found. Further, advancements in the bioinformatics field and its adoption in various segments of the market is also acting as a driving force for the target market globally. Moreover, increased adoption of the genomic and personalized medicine for the treatment of diseases also helps to flourish the market globally. For instance, according to The Personalized Medicine Coalition(PMC), in February 2018, over 30% of new drugs which were approved by Food and Drug Administration in 2017 were personalized medicine and 16 new personized medicine therapies were approved in the same year.  Additionally, with the beginning of targeted therapies in oncology and other fields of medicine has significantly transformed the companion diagnostics and has helped to thrive the global next-generation sequencing (NGS) market. However, lack of skills for the interpretation of the complex data is expected to limit the growth of the target market. Moreover, high cost of performing NGS and security related issues of the NGS data has also contributed to decline the global next-generation sequencing (NGS) market. The NGS is also emerging as a powerful promising pathogen-detection method for infectious-disease diagnostics which helps in the identification and genomic characterization of parasites, fungi, bacteria and viruses, directly from clinical specimens, without the need for prior knowledge of a specific pathogen. This acts as a trend and will help the global next-generation sequencing(NGS) market to grow rapidly. Further, reducing the cost of preforming of NGS and training persons for the interpretation of the NGS data will be a great opportunity to the global next-generation sequencing (NGS) market.

Simley face

Regional Analysis:

For detailed understanding of market dynamics, the global next-generation sequencing (NGS) market is analyzed across key regions viz North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the global market. In 2018, North America market dominates the global next-generation sequencing (NGS) market in terms of revenue followed by other regions and is expected to maintain its dominance over the forecast period. This is mainly due to the presence of major players, rising application of next-generation sequencing in genomics research, and increasing investments are major factors driving growth of North America next-generation sequencing (NGS) market. The Europe market accounts for second highest share in terms of revenue in the global market. The Europe next-generation sequencing (NGS) market is expected to witness moderate growth in terms of revenue during the forecast period.

Competitive Analysis:

Some of the prominent players operating in the global next-generation sequencing (NGS) market include include Thermo Fisher Scientific, Inc., Illumina Inc., QIAGEN, PierianDx, Inc., F Hoffman-La Roche Ltd., Genomatix GmbH, Oxford Nanopore Technologies, Eurofins GATC Biotech GmbH, DNASTAR, Inc., and Bio-Rad Laboratories, Inc. Technological advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the global next-generation sequencing (NGS) market. For instance, in January 2018, Thermo Fisher Scientific Introduces Ion GeneStudio S5 Series, A Line of Highly Versatile Next Generation Sequencers. Further, in January 2017, Bio-Rad Laboratories, Inc. declared that it has entered into a definitive agreement to buy RainDance Technologies, Inc. and Droplet Intellectual Property.

Market Taxonomy:

This report segments the global next-generation sequencing (NGS) market on the basis of technology, application, end user and region. On the basis of technology, the target market is divided into whole genome sequencing, whole exome sequencing, RNA sequencing, targeted re-sequencing and others. On the basis of application, the global next-generation sequencing (NGS) market is divided into drug discovery, personalized medicine & genetic screening, disease diagnosis, agriculture & animal research and others. On the basis of end user, the target market is divided as hospitals, research centers pharma & biotech firms and others. On the basis of region, the global next-generation sequencing (NGS) market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. 

Key features of the study:

Prophecy Market Insights provides detailed analysis on next-generation sequencing (NGS) market in our report- Global next-generation sequencing (NGS) Market by application, end-user, and region The report provides market size (US$ Mn) and compounded annual growth rate (%) for the forecast period: 2019 – 2029, considering 2018 as the actual year. The report also contains in-depth analysis about market drivers, restraints, opportunities, new product launches, product approval, ongoing trends, customers demand, and regional outlook. The report delivers competitive analysis about leading players in the global next-generation sequencing (NGS) market based on various parameters such as company overview, product portfolio, regional presence, financial performance, distribution strategies, key developments, marketing strategies, and future plans. The analysis from the report would acquaint the marketers and management authorities of companies to make the appropriate decision with respect to their future product launch, ongoing trends, market expansion, and marketing tactics used overall the globe. Various strategy matrices include in the report are PEST analysis, PORTER’s five forces analysis, and opportunity map analysis to analyze the next-generation sequencing (NGS) market.

Detailed Segmentation:

Global Next-Generation Sequencing (NGS) Market, By Technology:

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • RNA Sequencing
  • Targeted Re-sequencing
  • Others

Global Next-Generation Sequencing (NGS) Market, By Application:

  • Drug Discovery
  • Personalized Medicine & Genetic Screening
  • Disease Diagnosis
  • Agriculture & Animal Research
  • Others

Global Next-Generation Sequencing (NGS) Market, By End User:

  • Hospitals
  • Research Centers
  • Pharma & Biotech Firms
  • Others

Global Next-Generation Sequencing (NGS) Market, By Region:

  • North America
    • North America Next-Generation Sequencing (NGS) Market, By Technology
    • North America Next-Generation Sequencing (NGS) Market, By Application
    • North America Next-Generation Sequencing (NGS) Market, By End User
    • North America Next-Generation Sequencing (NGS) Market, By Country
      • S.
      • Canada
    • Europe
      • Europe Next-Generation Sequencing (NGS) Market, By Technology
      • Europe Next-Generation Sequencing (NGS) Market, By Application
      • Europe Next-Generation Sequencing (NGS) Market, By End User
      • Europe Next-Generation Sequencing (NGS) Market, By Country
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
      • Asia Pacific
        • Asia Pacific Next-Generation Sequencing (NGS) Market, By Technology
        • Asia Pacific Next-Generation Sequencing (NGS) Market, By Application
        • Asia Pacific Next-Generation Sequencing (NGS) Market, By End User
        • Asia Pacific Next-Generation Sequencing (NGS) Market, By Country
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific                                                                                                                                                                                                                                                                                                                                                                                                                                   
        • Latin America
          • Latin America Next-Generation Sequencing (NGS) Market, By Technology
          • Latin America Next-Generation Sequencing (NGS) Market, By Application
          • Latin America Next-Generation Sequencing (NGS) Market, By End User
          • Latin America Next-Generation Sequencing (NGS) Market, By Country
            • Brazil
            • Mexico
            • Rest of Latin America
          • Middle East & Africa
            • Middle East & Africa Next-Generation Sequencing (NGS) Market, By Technology
            • Middle East & Africa Next-Generation Sequencing (NGS) Market, By Application
            • Middle East & Africa Next-Generation Sequencing (NGS) Market, By End User
            • Middle East & Africa Next-Generation Sequencing (NGS) Market, By Country
              • GCC
              • Israel
              • South Africa
              • Rest of Middle East & Africa

Company Profile:

  • Thermo Fisher Scientific Inc.*
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Illumina Inc.
  • QIAGEN
  • PierianDx, Inc.
  • F Hoffman-La Roche Ltd.
  • Genomatix GmbH
  • Oxford Nanopore Technologies
  • Eurofins GATC Biotech GmbH
  • DNASTAR, Inc.
  • Bio-Rad Laboratories, Inc.

 “*” marked represents similar segmentation in other categories in the respective section

 

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Opportunity Map Analysis
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Market Trends
    • Product Launch
    • Impact Analysis
    • PEST Analysis
    • Porter’s Analysis
  4. Global Next-Generation Sequencing (NGS) Market, By Technology, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Whole Genome Sequencing
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    •  Whole Exome Sequencing
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    •  RNA Sequencing
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    •  Targeted Re-sequencing
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Others
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  1. Global Next-Generation Sequencing (NGS) Market, By Application, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Drug Discovery
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    •  Personalized Medicine & Genetic Screening
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Disease Diagnosis
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Agriculture & Animal Research
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Others
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  1. Global Next-Generation Sequencing (NGS) Market, By End-User, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Hospitals
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Research Centers Pharma & Biotech Firms
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Others
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  1. Global Next-Generation Sequencing (NGS) Market, By Region, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Region, 2019 – 2029
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Region, 2019 – 2029
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Region, 2019 – 2029
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Region, 2019 – 2029
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Region, 2019 – 2029
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  1. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      •  Thermo Fisher Scientific, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Illumina Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • QIAGEN
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • PierianDx, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • F Hoffman-La Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Genomatix GmbH
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Oxford Nanopore Technologies
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Eurofins GATC Biotech GmbH
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • DNASTAR, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Perkin Elmer, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
    • Analyst Views
  2. Section
    • Research Methodology
    • About Us
    • Contact

 

 

  • We at Prophecy Market Insights performs in-depth primary and secondary market research to identify market growth and restraining factors, opportunities, and trends, and to determine the key players in the target market, market size of the target market, leading products, leading applications in the target market, suppliers and distributors in the target market etc.
  • Primary Research – Prophecy Market Insights formulates a detailed discussion guide to perform primary research. In primary research collection of data is performed through telephonic interview, E-mail questionnaire’s, and in-depth discussion with industry experts, manufacturers, suppliers, distributors, and end-users. The primary research participant includes but not limited to CEO’s, Managers, Directors, VP’s, Suppliers, and CSO’s.
  • Secondary Research – Our research analyst performs in-depth secondary research and extensive data mining to collect market related information through various authentic data sources such as Government Portals, Annual Reports, Trade Publications, Clinical Trials Publications, Research Publications, Company Press Release, and some paid data sources.
  • In-house Data Analysis – After extensive data mining, we perform in-house market analysis by using various data tools, statistical methods, and data analysis tools to arrive on a conclusion and reduce the margin of error. We provide our overviews and market forecast for the target market after thoroughly understanding and analyzing of collected data, historic market trends, and research outputs.
  • Report Delivery – Prophecy Market Insights provide report in required electronic format (preferably in PDF format), as PDF format is easy to read and present.
How May I Help You ?

Facing difficulties to find research data that meet your requirement? We are here to assist you. Get in connect with our representative for your specific requirement.

Knowledge Center